Irritable bowel syndrome: Factors of importance for disease‐specific quality of life

Chloé Melchior (1, 2, 3, 4, 5) , Esther Colomier (1, 6) , Inês Trindade (7) , Mahrukh Khadija (1) , Jóhann Hreinsson (1) , Hans Törnblom (1) , Magnus Simrén (1, 8)

1 Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
2 ADEN - Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau
3 IRIB - Institute for Research and Innovation in Biomedicine
4 UNIROUEN UFR Santé - UNIROUEN - UFR Santé
5 Service d'Hépato-Gastroentérologie [CHU Rouen]
6 Department of Chronic Diseases, Metabolism and Aging (CHROMETA), Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium.
7 Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
8 UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, USA.

Domaines: Hépatologie et Gastroentérologie

Chloé Melchior, Esther Colomier, Inês Trindade, Mahrukh Khadija, Jóhann Hreinsson, et al.. Irritable bowel syndrome: Factors of importance for disease‐specific quality of life. United European Gastroenterology Journal, 2022, ⟨10.1002/ueg2.12277⟩. ⟨hal-03738339⟩